| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.085 | 0.06 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.099 | 0.06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.06 |